Omnia SanaPlant Comparison
Blue gum eucalyptus vs Black Cumin
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Blue gum eucalyptus and Black Cumin: they share 8 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Blue gum eucalyptus | Black Cumin | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 5/10 | Stronger for Black Cumin |
| Cold & flu | 2/10 | 5/10 | Stronger for Black Cumin |
| Immune support | 2/10 | 5/10 | Stronger for Black Cumin |
| Infection (general) | 2/10 | 5/10 | Stronger for Black Cumin |
| Inflammation (general) | 2/10 | 5/10 | Stronger for Black Cumin |
| Respiratory support | 2/10 | 5/10 | Stronger for Black Cumin |
| Skin irritation | 2/10 | 5/10 | Stronger for Black Cumin |
| Wounds | 2/10 | 5/10 | Stronger for Black Cumin |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
The principal bioactive constituent of the seed oil, responsible for much of its anti-inflammatory, antioxidant and antimicrobial activity.
The aromatic fraction of the seed, contributing antimicrobial and antioxidant activity.
The bulk lipid fraction of the seed (roughly a third of seed weight by weight), the carrier for the fat-soluble thymoquinone.
Minor isoquinoline-type alkaloids studied for antioxidant activity.
Triterpene saponin studied for anticancer and antiparasitic activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from analgesic action
inferred from digestive action
inferred from antidiabetic action
inferred from anticancer action
inferred from immunomodulator action
inferred from analgesic action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
Generally well-tolerated in clinical trials at doses up to 200 mg/day of oil for 90 days. Potential side effects may include mild gastrointestinal discomfort. Contraindicated during pregnancy due to potential uterine stimulant effects. May interact with immunosuppressants and antidiabetic medications. Allergic reactions possible in sensitive individuals. Consult healthcare provider before use, especially with concurrent medications.
Duke (2002) describes black cumin (Nigella sativa) as one of the most multi-active medicinal spices, with experimental evidence for bronchodilation, immunostimulation, hepatoprotection, and antihistaminic activity. The prophet Muhammad reportedly described it as 'a cure for all things except death.' Key bioactive compounds include thymoquinone and nigellone. Antihistaminic and bronchodilatory activity supports its traditional use in asthma and allergic conditions. Duke notes it is generally safe at culinary amounts but recommends caution with medicinal doses in pregnancy due to potential uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Annual herb (Ranunculaceae), 20-90 cm tall, with an erect, branched stem and finely divided, pinnately dissected, fern-like leaves. Delicate pale blue-white (occasionally pale purple) flowers, each with 5-10 petal-like sepals, are surrounded by a feathery bract collar. The fruit is an inflated, many-celled capsule that dries and splits to release numerous small, black, angular seeds - the medicinal part.[1]
Habitat
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Native to the Mediterranean basin, southern Europe, western Asia and North Africa, and widely cultivated as a spice and medicinal crop across the Middle East, South Asia and North Africa; grows in cultivated fields and on disturbed ground.[1]
Harvesting
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
Seed capsules are harvested once dried and brown (late summer), then threshed to release the small black seeds. Seed is stored whole and either used directly or cold-pressed for oil shortly before use to preserve the volatile thymoquinone-rich fraction.[1]
Traditional Uses
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
One of the most celebrated medicinal seeds in Middle Eastern and Islamic traditional medicine - known as 'Habbatul Barakah' (the blessed seed) - black seed has traditionally been used for digestive complaints, respiratory conditions (asthma, cough), pain, inflammation, skin conditions and as a general tonic. Modern research on its principal constituent thymoquinone supports broad anti-inflammatory, antioxidant, antimicrobial, antidiabetic and immunomodulatory activity.[1, 2, 9]
Preparations
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Dosage
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Hannan, M.A., Rahman, M.A., Sohag, A.A.M., Uddin, M.J., Dash, R., Sikder, M.H., Rahman, M.S., Timalsina, B., Munni, Y.A. and Sarker, P.P (2021) 'Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety', Nutrients, 13(6), pp. 1784. doi:10.3390/nu13061784 Meta-analysis / review
https://doi.org/10.3390/nu13061784 - Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., Damanhouri, Z.A. and Anwar, F (2013) 'A review on therapeutic potential of Nigella sativa: A miracle herb', Asian Pacific Journal of Tropical Biomedicine, 3(5), pp. 337-352. doi:10.1016/S2221-1691(13)60075-1 Meta-analysis / review
https://doi.org/10.1016/S2221-1691(13)60075-1 - Chatterjee, G., Saha, A.K., Khurshid, S. and Saha, A (2025) 'A Comprehensive Review of the Antioxidant, Antimicrobial, and Therapeutic Efficacies of Black Cumin (Nigella sativa L.) Seed Oil and Its Thymoquinone', Journal of Medicinal Food, 28(4), pp. 325-339. doi:10.1089/jmf.2024.k.0149 Meta-analysis / review
https://doi.org/10.1089/jmf.2024.k.0149 - Majdalawieh, A.F. and Fayyad, M.W (2015) 'Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review', International Immunopharmacology, 28(1), pp. 295-304. doi:10.1016/j.intimp.2015.06.023 Meta-analysis / review
https://doi.org/10.1016/j.intimp.2015.06.023 - Shaukat, A., Zaidi, A., Anwar, H. and Kizilbash, N (2023) 'Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review', Frontiers in Nutrition, 10, pp. 1126272. doi:10.3389/fnut.2023.1126272 Meta-analysis / review
https://doi.org/10.3389/fnut.2023.1126272 - Beheshti, F., Khazaei, M. and Hosseini, M (2016) 'Neuropharmacological effects of Nigella sativa', Avicenna Journal of Phytomedicine, 6(1), pp. 104-116. Meta-analysis / review
https://scholar.google.com/scholar?q=Neuropharmacological%20effects%20of%20Nigella%20sativa - Shafiq, H., Ahmad, A., Masud, T. and Kaleem, M (2014) 'Cardio-protective and anti-cancer therapeutic potential of Nigella sativa', Iranian Journal of Basic Medical Sciences, 17(12), pp. 967-979. Meta-analysis / review
https://scholar.google.com/scholar?q=Cardio-protective%20and%20anti-cancer%20therapeutic%20potential%20of%20Nigella%20sativa - Bordoni, L., Fedeli, D., Nasuti, C., Maggi, F., Papa, F., Wabitsch, M., De Caterina, R. and Gabbianelli, R (2019) 'Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes', Antioxidants, 8(2), pp. 51. doi:10.3390/antiox8020051 Preclinical
https://doi.org/10.3390/antiox8020051 - Gholamnezhad, Z., Havakhah, S. and Boskabady, M.H (2016) 'Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review', Journal of Ethnopharmacology, 190, pp. 372-386. doi:10.1016/j.jep.2016.06.061 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.061 - Ali, B.H. and Blunden, G (2003) 'Pharmacological and toxicological properties of Nigella sativa', Phytotherapy Research, 17(4), pp. 299-305. doi:10.1002/ptr.1309 Meta-analysis / review
https://doi.org/10.1002/ptr.1309 - Al-Attass, S.A., Zahran, F.M. and Turkistany, S.A (2016) 'Nigella sativa and its active constituent thymoquinone in oral health', Saudi Medical Journal, 37(3), pp. 235-244. doi:10.15537/smj.2016.3.13006 Meta-analysis / review
https://doi.org/10.15537/smj.2016.3.13006 - Ahmad A, Husain A, Mujeeb M, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3 (2013) ';3(5):337-352', 3(5). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ - Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015;95-96:138-158. https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ (2015) ';95-96:138-158'. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ - Forouzanfar F, Bazzaz BSF, Hosseinzadeh H. A review of ethnobotany, phytochemistry, antimicrobial pharmacology and toxicology of Nigella sativa L. Biomed Pharmacother. 2021;142:112040. https://www.sciencedirect.com/science/article/pii/S0753332221009665 (2021) ';142:112040'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221009665 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221009665 - Gholamnezhad Z, Keyhanmanesh R, Boskabady MH. Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases. Biomed Pharmacother. 2021;136:111240. https://www.sciencedirect.com/science/article/pii/S0753332221002778 (2021) ';136:111240'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221002778 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221002778 - Hannan MA, Rahman MA, Sohag AAM, et al. Black cumin (2021) ';13(6):1784', 13(6). doi:10.3389/fphar.2021.625386/full Randomized trial
https://doi.org/10.3389/fphar.2021.625386/full - Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, et al. Phytochemistry, pharmacology, and therapeutic uses of black seed (2016) ';22(3):231-237', 22(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ - Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (2017) ';20(3):179-193', 20(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Saadati, S., Naseri, K., Asbaghi, O., Abhari, K., Zhang, P., Li, H.B. and Gan, R.Y (2022) 'Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials', Frontiers in Nutrition, 9, pp. 977756. doi:10.3389/fnut.2022.977756 Meta-analysis / review
https://doi.org/10.3389/fnut.2022.977756 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016 - Sahebkar, A., Soranna, D., Liu, X., Thomopoulos, C., Simental-Mendia, L.E., Derosa, G., Maffioli, P. and Parati, G (2016) 'A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure', Journal of Hypertension, 34(11), pp. 2127-2135. doi:10.1097/HJH.0000000000001049 Meta-analysis / review
https://doi.org/10.1097/HJH.0000000000001049 - Kavyani, Z., Musazadeh, V., Safaei, E., Mohammadi Asmaroud, M., Khashakichafi, F., Ahrabi, S.S. and Dehghan, P (2023) 'Antihypertensive effects of Nigella sativa supplementation: an updated systematic review and meta-analysis of randomized controlled trials', Phytotherapy Research, 37(8), pp. 3224-3238. doi:10.1002/ptr.7891 Meta-analysis / review
https://doi.org/10.1002/ptr.7891
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.